Holds one active US DMF for metaxalone, filing since 2022. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 6 markets.
Holds one active US DMF for metaxalone, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 10 markets.
Holds 2 active US DMFs for metaxalone, filing since 2014. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds one active US DMF for metaxalone, filing since 2010. Its 2025 FDA inspection closed as NAI.
Holds 2 active US DMFs for metaxalone, filing since 2008. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for metaxalone, filing since 2021. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
This page filters the worldwide Metaxalone manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for metaxalone and what filings they hold.
Chat with Fred, your AI analyst